swissnex Startup Bootcamps

Empowering Swiss Startups to Internationalize.


Empowering Swiss Startups to Internationalize


swissnex is the launchpad for Swiss startups in the US. Our equity-free startup programs are customized to the needs of entrepreneurs exploring or entering the US market. With over a decade of experience accelerating the international success of companies such as Mindmaze, faceshift, and Ava, we tailor our toolbox sessions to each startup and offer critical business connections. By joining our community of innovators, Swiss startups gain visibility and a home base to succeed in the US.

Twice a year, swissnex brings together promising Swiss Startups for a two week bootcamp with toolbox sessions, fireside chats, special networking events, a demo night, and more. However it is possible to come to swissnex SF year-round, just indicate your preferred dates in the application.



The next swissnex Startup Bootcamp takes place in Spring 2021 (the date will be announced shortly). Applications are now accepted.
Important: Applying startups need to be in the
Innosuisse coaching program


Participants of the virtual October 2020 bootcamp

ASPIVIX | Mathieu HORRAS, Co-founder & CEO |

Every year, more than 80M women worldwide experience pain, bleeding and tissue tear when undergoing common gynecological procedures that require uterus access. This trauma is generated by the Cervical Tenaculum, an instrument with sharp hooks that pinch the cervix to generate traction. ASPIVIX is changing that by developing a next-generation vacuum-based cervical device that delivers the same maneuverability as the tenaculum without the reported patient trauma. This device is ideal to help address unplanned pregnancies, considered one of the most significant global public health issues, by increasing the adoption of Intrauterine Contraceptive Devices (IUD), the most effective reversible contraceptive option available today. ASPIVIX empowers women and makes them free to choose their contraception option without fear. Find them on Facebook, Instagram, Linkedin, Twitter, and YouTube.

Auxivo AG
| Volker Bartenbach, Co-founder & CEO.  Michael Stucky, Co-founder & Chairman. Fabio Gobbo, Business Developer |

Auxivo is a spinoff from ETH Zurich developing the next generation of lightweight exoskeletons to improve workers‘ lives. Follow them on Facebook, Instagram, Linkedin, and Twitter.

JAMIE & I | Antonia Bolla, Founder |

Welcome to Your Personal Online Boutique with Sustainable Designers you’ll LOVE! Curated by Jamie, your personal artificially intelligent online stylist who curates your personal online boutique with a curated selection of sustainable designers tailored to your style. Follow them on Instagram, and Linkedin.

MYLEG | Giacomo Valle, Postdoctoral Researcher at ETHZ |

MYLEG is a non-invasive sensory feedback to improve Mobility and to promote cognitive prosthesis integration in people with leg amputation.

Neurosoft Bioelectronics | Nicolas Vachicouras, CEO & Karsten Bagger, CBO |

Neurosoft Bioelectronics develops implantable medical devices to interface with the brain and spinal cord to treat patients suffering from neurological disorders. Our main USP is that we are the only ones to have been able to combine extremely soft materials that match the mechanical properties of the nervous tissues with high-density electrodes. Thanks to these unique features, we can access some locations of the brain that are impossible to reach surgically otherwise. Our preliminary animal data also suggest that our soft electrodes reduce dramatically inflammation when implanted. Follow them on Linkedin and Twitter.

Optimo Medical AG | Harald P. Studer, CEO & Alexander van der Mey, CCO |

Optimo Medical AG is specialized in bio-mechanical analyses and simulation of the anterior eye. Since the companies founding in 2015, the team has built a steady reputation as the leading company in virtual trials for the anterior eye segment, and a global technology leader in patient specific astigmatism management. Follow them on Linkedin.

Scailyte | Peter Nestorov, CEO. Stefan Almestrand, Director Corporate Development. Andrius Serva, Business Development Manager. Agnieszka Sitarska, Business Development Associate |

Scailyte uses single cell technologies and AI to discover biomarkers for diseases in oncology and immunology. We have a number of patented biomarker signatures which we currently are developing into clinical diagnostic applications for hospitals and subsequently patients. Follow them on Linkedin.


What We Offer




Since 2010, we’ve supported 98 Swiss startups.

We integrate a community of over 400 founders and organizations.

Our startup alumni have a combined valuation of $1.1B, and have created more than 500 jobs.

In the press

A digital bootcamp for seven Swiss startups to explore the US market ( – May 12, 2020)
A San Francisco startup guide for international entrepreneurs (Podium – August 13, 2019)
swissnex Startup Bootcamp: Off to San Francisco ( – August 7, 2019)
Go Global: The swissnex Startup Roadshow in Switzerland ( – May 14, 2019)
swissnex SF on CNN Money Switzerland (CNN – May 6, 2019)

Coaches & Speakers



  • Franziska Steiner, organizer, swissnexSF
  • Linda Aerne, organizer, swissnexSF


Swiss Community | The Swiss Startup News channel | The Swiss Startup News channel Atom-Feed: News

  • Investiere takes the next step in becoming a pan-European platform
    by Startupticker on November 26, 2020 at 3:52 pm

    Through an exclusive partnership, the Belgian business angel network BeAngels will offer Belgian investors access to the investiere platform and will contribute to sourcing new deal flow from Belgium as well. Swiss start-ups will benefit from the access to a larger network.

  • Abionic launches new tool for faster triage of Covid19 patients
    by Startupticker on November 26, 2020 at 9:55 am

    Abionic’s cSOFA score assesses the severity of Covid-19 among patients within only five minutes of analysing a blood sample. With the launch of the CE-Mark certified device, the company aims to prevent hospital overload by allowing health workers to assign patients to general wards, intensive care units or discharge them from the hospital.

  • Development milestones for startups with Corona solutions
    by Startupticker on November 25, 2020 at 3:56 pm

    Solutions to curb the Corona virus come in different variations: for instance, Ender Diagnostic is developing rapid and reliable COVID-19 tests while Molecular Partners and Metriopharm are working on new therapies. Receiving the FDA clearance and progressing on clinical trials are the latest accomplishments made by the three startups.

  • Lonza and Authena team up to improve crop protection
    by Startupticker on November 23, 2020 at 12:51 pm

    Lonza Crop Protection and the Swiss start-up company Authena are pioneering digital technology to improve product traceability and authenticity of crops. The technology will initially be piloted as a prototype in Brazil.

  • Samsung TV Plus launches in Europe
    by Startupticker on November 18, 2020 at 10:00 am

    Launching today, is joining Samsung TV Plus’s existing line up - providing a brand new F.A.S.T channel offering a stellar line up of over 200 shorts, which will be refreshed monthly. In addition, an extra 50 short films will be available on demand, enabling the user to watch anytime, anywhere - instantly on any Samsung TV. Both formats will be available free.